- Akston Biosciences: “Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA” (March 8, 2023)
- Seqens: “Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston: Multi-million Dollar Investment Signals Commitment to U.S. Market; Creates R&D Center of Excellence in Pharmaceutical Development and Manufacture” (Jan. 31, 2023)
- Akston Biosciences: “Akston Biosciences Strengthens Board with Addition of John T. Preston” (Jan. 23, 2023)
- Birnbach Communications: “Birnbach Communications Issues Key Media, Business and Tech Predictions for 2023: Trends include the rise of ChatGPT, the future of social media and Section 230, and aging electric grids” (Jan. 23, 2023)
- Hebrew SeniorLife: “Remote Protocols Broaden Reach of Delirium Care: Modified, extended program has potential to improve hospital care of older adults” (Jan. 13, 2023)
